| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, im..
>Volltext.. |
| 1159429.5 Mio. EUR |
| 1198820.86 Mio. EUR |
| 78868.54 Mio. EUR |
| 42404.04 Mio. EUR |
| 25155.98 Mio. EUR |
| 27.8 EUR |
| 45155.43 Mio. EUR |
| 4388.48 Mio. EUR |
| 27953.26 Mio. EUR |
| 0.1 |
| 50.73% |
| 55.15% |
| 6.01 EUR |
| 0.5% |
| 0.51% |
| 13.11.26 - 1.568764€ 14.08.26 - 1.494893€ >weitere anzeigen... |
| ELI LILLY, LILLY DEUTSCHLAND |
| 20.11.26 |
|
||||
|
||||
|
||||
|
||||
|